Free Trial

Bone Biologics (BBLGW) Short Interest Ratio & Short Volume

Bone Biologics logo
$32.24
0.00 (0.00%)
(As of 11/1/2024 ET)

Bone Biologics Short Interest Data

Bone Biologics (BBLGW) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 2,493 shares to cover all short positions.

Current Short Interest
100 shares
Previous Short Interest
100 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$4,162.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
June 15, 2024
Today's Trading Volume
325 shares
Average Trading Volume
2,493 shares
Today's Volume Vs. Average
13%
Short Selling Bone Biologics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Bone Biologics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BBLGW Short Interest Over Time

BBLGW Days to Cover Over Time

BBLGW Percentage of Float Shorted Over Time

Bone Biologics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/2024100 shares $4,162.00 No ChangeN/A0.1 $41.62
5/31/2024100 shares $4,162.00 -87.5%N/A0.1 $41.62
5/15/2024800 shares $55,632.00 +33.3%N/A0.8 $69.54
4/30/2024600 shares $14,340.00 -53.9%N/A0.6 $23.90
4/15/20241,300 shares $24,700.00 +44.4%N/A0.7 $19.00
3/31/2024900 shares $15,480.00 +80.0%N/A0.4 $17.20
3/15/2024500 shares $9,850.00 -37.5%N/A0.1 $19.70
2/29/2024800 shares $4,888.00 +700.0%N/A0.2 $6.11
2/15/2024100 shares $500.00 -75.0%N/A0 $5.00
1/31/2024400 shares $5,996.00 No ChangeN/A0.1 $14.99

BBLGW Short Interest - Frequently Asked Questions

What is Bone Biologics' current short interest?

Short interest is the volume of Bone Biologics shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 100 shares of BBLGW short. Learn More on Bone Biologics' current short interest.

How does Bone Biologics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "medical equipment" compare to Bone Biologics: Stevanato Group S.p.A. (8.29%), Zimmer Biomet Holdings, Inc. (2.83%), Smith & Nephew plc (0.61%), Solventum Co. (3.23%), Penumbra, Inc. (6.82%), Bausch + Lomb Co. (3.92%), Glaukos Co. (4.33%), Inspire Medical Systems, Inc. (6.40%), TransMedics Group, Inc. (19.19%), Axonics, Inc. (6.14%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($5.04 billion), T-Mobile US, Inc. ($4.49 billion), Charter Communications, Inc. ($3.25 billion), Moderna, Inc. ($3.02 billion), General Motors ($2.91 billion), Royal Caribbean Cruises Ltd. ($2.37 billion), Cencora, Inc. ($2.19 billion), Tractor Supply ($1.82 billion), Williams-Sonoma, Inc. ($1.72 billion), and Enphase Energy, Inc. ($1.61 billion). View all of the most shorted stocks.

What does it mean to sell short Bone Biologics stock?

Short selling BBLGW is an investing strategy that aims to generate trading profit from Bone Biologics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bone Biologics?

A short squeeze for Bone Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BBLGW, which in turn drives the price of the stock up even further.

How often is Bone Biologics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBLGW, twice per month. The most recent reporting period available is June, 15 2024.




This page (NASDAQ:BBLGW) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners